Shsh...???
???
TopiCure
TopiCure offers eutectogel wound dressings that combine a biocompatible hydrogel matrix with sustained‑release antimicrobial agents.
- Healthcare Technology
- Medical Devices
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Many patients suffer from chronic or non‑healing wounds that are prone to infection, require frequent dressing changes, and often heal slowly due to inadequate moisture management and ineffective drug delivery.
Solution
TopiCure addresses these issues with eutectogel wound dressings that combine a biocompatible hydrogel matrix with a sustained‑release antimicrobial payload. The gel maintains a moist environment without evaporating, adapts to the wound’s condition, and continuously releases therapeutic agents directly at the infection site. This approach reduces bacterial load, minimizes dressing changes, and promotes faster epithelial regeneration, offering a more efficient and cost‑effective alternative to conventional dressings.
Target Audience
Primary customers are wound‑care clinics, hospitals, and long‑term care facilities that treat chronic, diabetic, or post‑surgical wounds, as well as home‑care providers seeking advanced dressing solutions.
Features
- Biocompatible, skin‑friendly components free of harsh chemicals, suitable for sensitive or compromised skin
- Nanoscience‑engineered eutectogel structure that provides controlled, prolonged release of antimicrobial agents
- Non‑evaporating hydrogel that sustains optimal wound hydration throughout the healing process
- Lightweight, non‑sticky formulation that feels soothing on application and reduces irritation
- Enhanced skin permeation and dynamic adaptation to infection‑prone wounds for improved therapeutic efficacy